Differential Expression of NOTCH-1 and Its Molecular Targets in Response to Metronomic Followed by Conventional Therapy in a Patient with Advanced Triple-Negative Breast Cancer. The gene discussed is NOTCH1; the disease is triple-negative breast carcinoma.